C反应蛋白测定试剂盒(散射比浊法)CardioPhase hsCRP,由包被 C 反应蛋白的小鼠单克隆抗体的聚苯乙烯颗粒悬浊液构成。防腐剂:庆大霉素 6.25 mg/L,两性霉素 0.625 mg/L。,C反应蛋白测定试剂盒(散射比浊法)CardioPhase hsCRP,<<me_syfw>。
2021年,RESCUE研究证实(II期)15,IL-6单克隆抗体泽韦奇单抗能显著下降慢性肾病(CKD)患者hs-CRP水平,CKD患者是ASCVD的高危患者,研究提示泽韦奇单抗无显著毒性反应,对血脂参数无不良影响。目前,在ASCVD疾病患者、CKD患者和系统性炎症性疾病患者中开展的...
CardioPhase hsCRP由Dade Behring Marburg GmbH生产,注册证编号为:国食药监械(进)字2008第2403330号。该产品用于使用BN*系统通过颗粒强化的免疫散射比浊法定量测定人血清、肝素与EDTA抗凝血浆中的C-反应蛋白(CRP)。
3 year shelf life at -25° to -15°C; 30 days open-vial at 2° to 8°C (for hsCRP, Digitoxin, Troponin I and Homocysteine); 15 days open-vial at 2° to 8°C (for BNP32, Myoglobin (when a dropper tip is used), proBNP, Troponin T, CK-MB) LabLink xL quality assurance soft...
(−4.0 to 0.1) .06 HSCRP level, mg/dL 0.35 (0.39) 0.26 (0.29) −0.08 (0.39) .18 0.29 (0.46) 0.41 (0.72) 0.12 (0.66) .35 −0.2 (−0.5 to 0.1) .12 Physical activity, METs/min/wk 349.6 (530.6) 1384.7 (893.9) 1035.2 (735.7) <.001 519.7 (467.9) 553.8 (608....
The medians of eGFR, CRP and hs-cTnT level were 83.32 (IQR, 63.08–97.41) mL/min per 1.73 m2, 3.60 (IQR, 1.60–7.60) mg/L and 9.92 (IQR, 6.12–16.62) ng/L, respectively, with no significant difference between the three time periods. Levels of cardiac biomarkers (hs-cTnT and hs...
Using these cut-points, the high risk group for men and women had significantly higher BP, a more adverse lipid profile, was more insulin resistant as assessed by HOMA-IR, or the Matsuda index and had higher hs-CRP concentrations for men and women. Combined, approximately 25% of highest ...
CRP is an acute phase reactant produced by hepatocytes due to simulation by interleukin-6 produced by macrophages and T cells [110]. Elevated hsCRP is associated with decreased LVEF in patients with varying cardiovascular disease ranging from myocardial infarction and HF [110]. A study involving ...
negative predictive value hs-CRP: high-sensitivity C-reactive protein HDLc: high density lipoprotein cholesterol SBP: systolic blood pressure DBP: diastolic blood pressure TG: triglyceride BMI: body mass index.References Ruhl CE, Everhart JE: Determinants of the association of overweight with...
(hs-CRP) ≥ 2 mg/L. the primary result was the reduction of hs-CRP and IL-6 levels in a dose-dependent manner, associated with a reduced incidence of the composite outcome consisting in non-fatal myocardial infarction, non-fatal stroke, or cardiovascular death for the 150 mg and ...